Navigation Links
Seattle based non-profit, The Institute for Venture Science (IVS) today announced receipt of a significant operating grant from 1Plus12 Corporation.

Seattle based non-profit, The Institute for Venture Science (IVS) today announced receipt of a significant operating grant from 1Plus12 Corporation. The grant will be used to further the scientific research goals of the Institute and to commence pre-proposal activities as outlined on the organization's website

In accounting the grant to the IVS, Mr. Glenn Estrabillo of Toronto Canada, the CEO of 1Plus12 Corporation, explained that he was impressed with the goals and objectives of the IVS and that he hoped to assist in implementing the yet to be identified research projects supported by the IVS. “Not only am I pleased to have arranged this contribution, I am also pleased to have agreed to serve on the Board of Directors of the IVS”. In addition to Mr. Estrabillo’s service, Mr. Sai Mohammed and Mr. James Destephanis of the 1Plus12 Corporation have agreed to participate as members of the IVS Advisory Panel.

In regards to the announcement of Mr. Estrabillo’s participation in the organization, Dr. James Ryder, Chairman of the Institute for Venture Science commented, “it is a delight to have a new member of the board closely connected to the investment world and with a focus on helping others to empower themselves”.

Dr. Ryder also announced the selection of Dr. Beverly Rubik as an additional member of the Board of Directors. In announcing Dr. Rubik, Dr. Ryder said, “we are pleased to have a board member with the experience of having been involved in the issues of fostering a broadening in scientific thought”. Dr. Rubik commented, “Scientific research that challenges the mainstream is extremely rare because it is so difficult to find the necessary support. There is a serious need for novel approaches in science, and IVS takes a leadership role in facilitating this at its best.”

The IVS held its launch symposium in September 2015 with noted speakers and attendees, including several Nobel laureates. The organization hopes to help fund promising ideas that challenge conventional thinking through a unique multi-locational approach to such issues. The IVS has called for “pre-proposals” to identify areas of exploration.

The organization continues its fund drive to be able to fund anticipated worthwhile investigations.

Further information can obtained by visiting or by email harold(at)ivsci(dot)org.

Read the full story at

Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved

Related biology technology :

1. Todays Technical View: Elan Corp., Amarin, Seattle Genetics, and Cubist Pharma
2. Affordable Scrum Training in Seattle, WA – 8 PDUs by Conscires Agile Practices
3. Seattle Childrens shares results of national study tracking cognitive development of children with craniosynostosis
4. Seattle Childrens Opens Patient Enrollment for First Tumor Paint Clinical Trial for Children With Brain Cancer
5. Seattle Biotech Firm, SpringStar, Steps-Up Fight Against Zika and Dengue Fever
6. BioGenex Will Introduce Fully Integrated miRNA-ISH System for Tumor Diagnosis and Clinical Research at the USCAP Annual Meeting in Seattle, WA
7. Nabsys Secures $20 Million Series D Financing to Support Launch of Semiconductor-Based Single-Molecule Platform for Genomic Analysis
8. Connecticut-Based Contract Staffing Recruiters Adds More Career Boards and Staff
9. SRI International Licenses Bed Bug Detection Technology to Redcoat, a Virginia-Based Start-Up Company
10. Leading Chemical Manufacturer Expands Biobased Offering through Unique Distribution of Proven Green Spill Absorbent
11. Report Says Mold Stirs Herndon High School, My Cleaning Products Asserts Organic-Based and No-Scrubbing Mold Remediation Products Are the Answers to the Mold Problem
Post Your Comments:
(Date:10/11/2017)... the Netherlands and LAGUNA HILLS, Calif. ... The Institute of Cancer Research, London ... use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients ... trial known as MUK nine . The University of ... trial, which is partly funded by Myeloma UK, and ICR ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... the implantation and pregnancy rates in frozen and fresh in vitro fertilization ... progesterone and maternal age to IVF success. , After comparing the results from ...
(Date:10/10/2017)... ... October 10, 2017 , ... San Diego-based team building ... corporate rebranding initiative announced today. The bold new look is part of a ... company moves into a significant growth period. , It will also expand its service ...
(Date:10/10/2017)... ... October 10, 2017 , ... For the second time in ... STEM Mentoring Award. Representatives of the FirstHand program travelled to Washington, D.C. Tuesday, ... , US2020’s mission is to change the trajectory of STEM education in America ...
Breaking Biology Technology:
(Date:4/17/2017)... , April 17, 2017 NXT-ID, Inc. (NASDAQ: ... announces the filing of its 2016 Annual Report on Form 10-K ... Commission. ... 10-K is available in the Investor Relations section of the Company,s ... the SEC,s website at . 2016 Year ...
(Date:4/11/2017)... Apr. 11, 2017 Research and Markets has ... report to their offering. ... The global eye tracking market to grow at a CAGR of ... Eye Tracking Market 2017-2021, has been prepared based on an in-depth ... market landscape and its growth prospects over the coming years. The ...
(Date:4/5/2017)... , April 5, 2017  The Allen Institute ... Allen Cell Explorer: a one-of-a-kind portal and dynamic digital ... 3D imaging data, the first application of deep learning ... human stem cell lines and a growing suite of ... platform for these and future publicly available resources created ...
Breaking Biology News(10 mins):